The Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS): progress toward understanding suicide among soldiers
- PMID: 30104726
- PMCID: PMC6756108
- DOI: 10.1038/s41380-018-0197-z
The Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS): progress toward understanding suicide among soldiers
Abstract
Responding to an unprecedented increase in the suicide rate among soldiers, in 2008 the US Army and US National Institute of Mental Health funded the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS), a multicomponent epidemiological and neurobiological study of risk and resilience factors for suicidal thoughts and behaviors, and their psychopathological correlates among Army personnel. Using a combination of administrative records, representative surveys, computerized neurocognitive tests, and blood samples, Army STARRS and its longitudinal follow-up study (STARRS-LS) are designed to identify potentially actionable findings to inform the Army's suicide prevention efforts. The current report presents a broad overview of Army STARRS and its findings to date on suicide deaths, attempts, and ideation, as well as other important outcomes that may increase suicide risk (e.g., mental disorders, sexual assault victimization). The findings highlight the complexity of environmental and genetic risk and protective factors in different settings and contexts, and the importance of life and career history in understanding suicidal thoughts and behaviors.
Conflict of interest statement
In the past 3 years, RCK received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services, Inc. Lake Nona Life Project. RCK is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. MBS has been a consultant for Actelion Pharmaceuticals, Healthcare Management Technologies, Janssen Pharmaceuticals, Pfizer, Remedy Therapeutics, Oxeia Biopharmaceuticals, and Tonix Pharmaceuticals. The remaining authors declare that they have no conflict of interest.
Figures





References
-
- Eaton KM, Messer SC, Wilson ALG, Hoge CW. Strengthening the validity of population-based suicide rate comparisons: an illustration using U.S. military and civilian data. Suicide Life Threat Behav. 2006;36:182–191. - PubMed
-
- Black SA, Gallaway MS, Bell MR, Ritchie EC. Prevalence and risk factors associated with suicides of army soldiers 2001–2009. Mil Psychol. 2011;23:433–51.
-
- Reger MA, Pruitt LD, Smolenski DJ. Lessons from the latest US military suicide surveillance data. J Clin Psychiatry. 2018;79:17l11790. - PubMed
-
- Ingram RE, Luxton DD. Vulnerability-stress models. In: Hankin BL, Abela JRZ, editors. Development of psychopathology: a vulnerability-stress perspective. Thousand Oaks, CA: Sage; 2005. pp. 32–46.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical